News
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the 10 Stocks Going Wild. Summit Therapeutics jumped by 7.61 percent on ...
AstraZeneca PLC (NASDAQ:AZN) is one of the best high growth stocks. Bloomberg reported on July 3 that AstraZeneca is engaged ...
After several PD-1xVEGF competitors forged alliances with Big Pharma players, Summit Therapeutics, the frontrunner in this hot cancer drug field, is reportedly seeking its own deal. | After several PD ...
Shares in Summit Therapeutics have risen sharply on a report that AstraZeneca is in discussions for a partnership focused on PD-1xVEGF bispecific ivonescimab that is estimated to be worth as much ...
Summit Therapeutics jumped by 7.61 percent on Wednesday, a second day, to close at $24.74 apiece as reports about a $15-billion partnership with AstraZeneca continued to excite investors.
Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, Bloomberg News reported that AstraZeneca (NASDAQ: AZN) is in discussions ...
Since ADBA published its report on the role of green gases in December last year, the first unsubsidised biomethane plant has ...
The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the week and a look at ...
AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results